Armbrust American

Lloyd Armbrust and Emily Colman launched RonanRX, an AI-assisted care platform that uses patient data to help physicians personalize compounded GLP-1 doses, with its public launch as of September 2, 2…

RonanRx, an AI-assisted GLP-1 care platform founded by Lloyd Armbrust and Emily Colman, launched August 4th in Y Combinator's Summer 2026 batch, but its service currently operates only in Texas despit…